Evaluation of serum apolipoprotein concentrations and atherogenic indices in menopausal and premenopausal women in Nkwelle-Ezunaka

Amara Anthonia Okereke *, Patrick Onochie Manafa, Augustine Chinedu Ihim, Collins Uchechukwu Obi, Nkiruka Chinenye Nwoka and Stellamaris Chinenye Okeke

Department of Chemical Pathology, Faculty of Medical Laboratory Sciences, Nnamdi Azikiwe University, Awka, Nigeria.
 
Research Article
Magna Scientia Advanced Research and Reviews, 2024, 12(01), 159–165
Article DOI: 10.30574/msarr.2024.12.1.0150
Publication history: 
Received on 13 August 2024; revised on 08 October 2024; accepted on 11 October 2024
 
Abstract: 
Background of study: The hormonal change in menopause affects lipid metabolism which could lead to dyslipidaemia, a risk factor for cardiovascular disease. Aim of study: To evaluate the levels of apolipoprotein A1, apolipoprotein B, Castelli risk index-1, Castelli risk index-11, atherogenic index of plasma and atherogenic coefficient in menopausal and premenopausal women.
 Materials and Methods: In this cross-sectional study ninety females were selected which consisted of 45 premenopausal, and 45 menopausal women using simple random sampling technique. Levels of apolipoprotein A1 and B were determined spectrophotometrically using enzyme linked immunosorbent assay (ELISA). Atherogenic indices were calculated with their respective formulas.
Results: There was no significant difference in the mean levels of apo B (134.83±28.90 vs 130.73±30.55; p>0.05), apo A1, atherogenic index of plasma, Castelli risk index-1, Castelli risk index-11 and atherogenic coefficient  in the menopausal women  compared with the premenopausal women but the mean values of both groups were outside the normal range of apo B, Castelli risk index-1, atherogenic index of plasma and atherogenic coefficient.
Conclusion: Apo B, atherogenic index of plasma, Castelli risk index-1 and atherogenic coefficient are better indicators of cardiovascular risk.
 
Keywords: 
Apolipoprotein B; Atherogenic indices; Cardiovascular disease; Metabolic syndrome; Dyslipidaemia; Menopause;  Premenopause
 
Full text article in PDF: